PTEN and colorectal carcinoma: The associations between clinicopathological features and the expression of PTEN, AKT, ERK, and P65 markers provide a basis for further investigations into the precise roles of these signaling pathways in various stages of CRC development, aiding in the understanding of potential therapeutic targets and prognostic markers.